Looking for blood markers in systemic histiocytosis
Part of Blood & lymphatic clinical trials.
This study is looking for proteins or other markers in your blood that could help doctors better understand and monitor systemic histiocytosis, a rare condition where certain immune cells build up in your body. If you join, researchers will study your blood samples to help improve future care for people with your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have been diagnosed with systemic histiocytosis.
- You must already be receiving care at the Internal Medicine Department 2 at Pitié-Salpêtrière Hospital in Paris.
- You cannot be pregnant or breastfeeding.
- You must have French social security coverage (not AME).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for adults with Langerhans cell histiocytosis (LCH) and also for adults with certain lung conditions (like cystic lung disease or emphysema) or healthy smokers to act as controls. The goal is to find biomarkers (signs in the body) that can help doctors diagnose LCH, predict how it will progress, and see how well treatment is working.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This study creates a bank of leftover blood and other samples from patients at two French hospitals. It helps researchers test new, faster ways to diagnose diseases.
This study looks at people with histiocytic disorders, which are rare conditions where certain immune cells grow too much. It aims to learn more about these disorders to improve diagnosis and treatment.
This study looks for markers of cancer in your blood. It may help doctors learn more about your tumor and how to treat it.
This study looks at blood samples from people with blood cancers to find markers that might predict how well immunotherapy will work. The goal is to help doctors choose the right treatment for each person.
Hear when a new Systemic Histiocytosis (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.